354 related articles for article (PubMed ID: 16180231)
21. Axillary reverse mapping: mapping and preserving arm lymphatics may be important in preventing lymphedema during sentinel lymph node biopsy.
Boneti C; Korourian S; Bland K; Cox K; Adkins LL; Henry-Tillman RS; Klimberg VS
J Am Coll Surg; 2008 May; 206(5):1038-42; discussion 1042-4. PubMed ID: 18471751
[TBL] [Abstract][Full Text] [Related]
22. Implementation of sentinel node biopsy in breast cancer patients in the Netherlands.
Ho VK; van der Heiden-van der Loo M; Rutgers EJ; van Diest PJ; Hobbelink MG; Tjan-Heijnen VC; Dirx MJ; Reedijk AM; van Dijck JA; van de Poll-Franse LV; Schaapveld M; Peeters PH
Eur J Cancer; 2008 Mar; 44(5):683-91. PubMed ID: 18314328
[TBL] [Abstract][Full Text] [Related]
23. Arm morbidity and disability after breast cancer: new directions for care.
Thomas-Maclean RL; Hack T; Kwan W; Towers A; Miedema B; Tilley A
Oncol Nurs Forum; 2008 Jan; 35(1):65-71. PubMed ID: 18192154
[TBL] [Abstract][Full Text] [Related]
24. Early self-reported impairments in arm functioning of primary breast cancer patients predict late side effects of axillary lymph node dissection: results from a population-based cohort study.
Albert US; Koller M; Kopp I; Lorenz W; Schulz KD; Wagner U
Breast Cancer Res Treat; 2006 Dec; 100(3):285-92. PubMed ID: 16710790
[TBL] [Abstract][Full Text] [Related]
25. Morbidity in breast cancer patients with sentinel node metastases undergoing delayed axillary lymph node dissection (ALND) compared with immediate ALND.
Goyal A; Newcombe RG; Chhabra A; Mansel RE
Ann Surg Oncol; 2008 Jan; 15(1):262-7. PubMed ID: 17879117
[TBL] [Abstract][Full Text] [Related]
26. The feasibility of sentinel node biopsy in the previously treated breast.
Koizumi M; Koyama M; Tada K; Nishimura S; Miyagi Y; Makita M; Yoshimoto M; Iwase T; Horii R; Akiyama F; Saga T
Eur J Surg Oncol; 2008 Apr; 34(4):365-8. PubMed ID: 17532172
[TBL] [Abstract][Full Text] [Related]
27. Management of the axilla in operable breast cancer treated by breast conservation: a randomized clinical trial. Edinburgh Breast Unit.
Chetty U; Jack W; Prescott RJ; Tyler C; Rodger A
Br J Surg; 2000 Feb; 87(2):163-9. PubMed ID: 10671921
[TBL] [Abstract][Full Text] [Related]
28. Prospective evaluation of the morbidity of axillary clearance for breast cancer.
Duff M; Hill AD; McGreal G; Walsh S; McDermott EW; O'Higgins NJ
Br J Surg; 2001 Jan; 88(1):114-7. PubMed ID: 11136322
[TBL] [Abstract][Full Text] [Related]
29. Lymphoedema and reduced shoulder function as indicators of quality of life after axillary lymph node dissection for invasive breast cancer.
Voogd AC; Ververs JM; Vingerhoets AJ; Roumen RM; Coebergh JW; Crommelin MA
Br J Surg; 2003 Jan; 90(1):76-81. PubMed ID: 12520579
[TBL] [Abstract][Full Text] [Related]
30. Comparing patients' and clinicians' assessment of outcomes in a randomised trial of sentinel node biopsy for breast cancer (the RACS SNAC trial).
Smith MJ; Gill PG; Wetzig N; Sourjina T; Gebski V; Ung O; Campbell I; Kollias J; Coskinas X; Macphee A; Young L; Simes RJ; Stockler MR;
Breast Cancer Res Treat; 2009 Sep; 117(1):99-109. PubMed ID: 18925434
[TBL] [Abstract][Full Text] [Related]
31. Medium-term follow-up data after sentinel node biopsy alone for breast cancer.
Haid A; Knauer M; Köberle-Wührer R; Ammann K; Koller L; Eiter H; Lang A; Wenzl E
Eur J Surg Oncol; 2006 Dec; 32(10):1180-5. PubMed ID: 16750344
[TBL] [Abstract][Full Text] [Related]
32. Lymphedema following breast cancer treatment, including sentinel lymph node biopsy.
Armer J; Fu MR; Wainstock JM; Zagar E; Jacobs LK
Lymphology; 2004 Jun; 37(2):73-91. PubMed ID: 15328760
[TBL] [Abstract][Full Text] [Related]
33. Outcome of axillary staging in early breast cancer: a meta-analysis.
Kell MR; Burke JP; Barry M; Morrow M
Breast Cancer Res Treat; 2010 Apr; 120(2):441-447. PubMed ID: 20063121
[TBL] [Abstract][Full Text] [Related]
34. Arm and shoulder morbidity in breast cancer patients after breast-conserving therapy versus mastectomy.
Nesvold IL; Dahl AA; Løkkevik E; Marit Mengshoel A; Fosså SD
Acta Oncol; 2008; 47(5):835-42. PubMed ID: 18568481
[TBL] [Abstract][Full Text] [Related]
35. Sentinel node biopsy is not sensible in breast cancer patients with large primary tumours.
Leidenius MH; Krogerus LA; Toivonen TS; von Smitten KA
Eur J Surg Oncol; 2005 May; 31(4):364-8. PubMed ID: 15837040
[TBL] [Abstract][Full Text] [Related]
36. A longitudinal study of shoulder and arm morbidity in breast cancer survivors 7 years after sentinel lymph node biopsy or axillary lymph node dissection.
Kootstra JJ; Dijkstra PU; Rietman H; de Vries J; Baas P; Geertzen JH; Hoekstra HJ; Hoekstra-Weebers JE
Breast Cancer Res Treat; 2013 May; 139(1):125-34. PubMed ID: 23588950
[TBL] [Abstract][Full Text] [Related]
37. Incidence of arm lymphoedema following sentinel node biopsy, axillary sampling and axillary dissection in patients with breast cancer.
Lumachi F; Basso SM; Bonamini M; Marino F; Marzano B; Milan E; Waclaw BU; Chiara GB
In Vivo; 2009; 23(6):1017-20. PubMed ID: 20023249
[TBL] [Abstract][Full Text] [Related]
38. Implications of a postoperative rehabilitation program on quality of life in women with primary breast cancer treated with sentinel lymph node biopsy or complete axillary lymph node dissection.
Pinto e Silva MP; Sarian LO; Morais SS; Pace do Amaral MT; Freire de Oliveira MM; Derchain S
Ann Surg Oncol; 2008 Dec; 15(12):3342-9. PubMed ID: 18931880
[TBL] [Abstract][Full Text] [Related]
39. Self-perceived, but not objective lymphoedema is associated with decreased long-term health-related quality of life after breast cancer surgery.
Sackey H; Johansson H; Sandelin K; Liljegren G; MacLean G; Frisell J; Brandberg Y
Eur J Surg Oncol; 2015 Apr; 41(4):577-84. PubMed ID: 25659877
[TBL] [Abstract][Full Text] [Related]
40. Post lymphadenectomy complications and quality of life among breast cancer patients in Brazil.
Paim CR; de Paula Lima ED; Fu MR; de Paula Lima A; Cassali GD
Cancer Nurs; 2008; 31(4):302-9; quiz 310-1. PubMed ID: 18600117
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
